Use of a Small Molecule Integrin Activator as a Systemically Administered Vaccine Adjuvant in Controlling Chagas Disease

Scientists described the adjuvant properties of a small molecule activator of the integrins αLβ2 and α4β1, named 7HP349, which could be safely delivered systemically independent of antigen.